CID 6478800

Schembl7483384

Structural Information

Molecular Formula
C35H50N4OS
SMILES
CCCCCCCC/C=C/CCCCCCCC(=O)NC1=NN=C(S1)NCCC(C2=CC=CC=C2)C3=CC=CC=C3
InChI
InChI=1S/C35H50N4OS/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-22-27-33(40)37-35-39-38-34(41-35)36-29-28-32(30-23-18-16-19-24-30)31-25-20-17-21-26-31/h9-10,16-21,23-26,32H,2-8,11-15,22,27-29H2,1H3,(H,36,38)(H,37,39,40)/b10-9+
InChIKey
FFZIALNITRWBQT-MDZDMXLPSA-N
Compound name
(E)-N-[5-(3,3-diphenylpropylamino)-1,3,4-thiadiazol-2-yl]octadec-9-enamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

3
Patents

574.37054 Da
Monoisotopic Mass

11.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 575.37782 245.3
[M+Na]+ 597.35976 243.2
[M-H]- 573.36326 249.0
[M+NH4]+ 592.40436 247.3
[M+K]+ 613.33370 233.7
[M+H-H2O]+ 557.36780 232.3
[M+HCOO]- 619.36874 257.9
[M+CH3COO]- 633.38439 259.2
[M+Na-2H]- 595.34521 239.3
[M]+ 574.36999 250.4
[M]- 574.37109 250.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe